Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Neoprobe and Dow enter licensing agreement

June 7, 1996

Research agreement: TCPI and the University of Kansas

June 7, 1996

CompuMed and the University of Massachusetts Medical Center enter agreement

June 7, 1996

Patient enrollment for Alkermes' RMP-7 trials complete

June 7, 1996

Pharmacopeia and Akzo Nobel: Drug discovery collaboration

June 7, 1996

Chiron and Kosan Biosciences commence collaboration

May 31, 1996

University of Connecticut awarded U.S. patent on licensed gene delivery technology

May 31, 1996

Promoter region responsible for controlling leptin gene-expression discovered

May 31, 1996

Creative BioMolecules, Purdue Research Foundation enter collaborative agreement

May 31, 1996

Cubist awarded phase II SBIR grants

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...